Benefits and Risks Associated With Continuation of Anti–Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Benefits and Risks Associated With Continuation of Anti–Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease

Published:2022-10 Issue:10 Volume:175 Page:1374-1382
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Meyer Antoine¹^ORCID,Neumann Anke²^ORCID,Drouin Jérôme²^ORCID,Weill Alain²^ORCID,Carbonnel Franck³^ORCID,Dray-Spira Rosemary²^ORCID

Affiliation:

1. EPI-PHARE, Épidémiologie des produits de santé, Saint-Denis, and Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre & Université Paris-Saclay, Le Kremlin Bicêtre, France (A.M.)

2. EPI-PHARE, Épidémiologie des produits de santé, Saint-Denis, France (A.N., J.D., A.W., R.D.)

3. Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre & Université Paris-Saclay, Le Kremlin Bicêtre, France (F.C.).

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Reference36 articles.

1. Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century

2. Health-Risk Behaviors and Chronic Conditions Among Adults with Inflammatory Bowel Disease — United States, 2015 and 2016

3. Inflammatory Bowel Disease: A Canadian Burden of Illness Review

4. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

5. The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal, prenatal and postnatal risk factors for early child physical abuse: a French nationwide cohort study;The Lancet Regional Health - Europe;2024-07

2. Live Rotavirus Vaccination Appears Low-risk in Infants Born to Mothers With Inflammatory Bowel Disease on Biologics;Clinical Gastroenterology and Hepatology;2024-07

3. Risk of Gastrointestinal Perforation in Patients With Rheumatic Diseases Exposed to Janus Kinase Inhibitors Versus Adalimumab: A Nationwide Cohort Study;Arthritis & Rheumatology;2024-05-30

4. Medically Assisted Reproduction and Risk of Cancer Among Offspring;JAMA Network Open;2024-05-02

5. Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation;The Lancet;2024-03